Salsali, Afshin: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Nishimura, Rimei, Tanaka, Yuko, Koiwai, Kazuki, Ishida, Kosuke, Salsali, Afshin, Kaspers, Stefan, Kohler, Sven, Lund, Søren S.

Journal:

Advances in Therapy

Year:

2019

Language:

english

File:

PDF, 1.67 MB

english, 2019

2

Empagliflozin compared with glimepiride in metformin-treated patients with type 2 diabetes: 208-week data from a masked randomized controlled trial

Ridderstråle, Martin, Rosenstock, Julio, Andersen, Knut Robert, Woerle, Hans J., Salsali, Afshin

Journal:

Diabetes, Obesity and Metabolism

Year:

2018

Language:

english

File:

PDF, 1.47 MB

english, 2018

3

Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial

Anker, Stefan D., Butler, Javed, Filippatos, Gerasimos S., Jamal, Waheed, Salsali, Afshin, Schnee, Janet, Kimura, Karen, Zeller, Cordula, George, Jyothis, Brueckmann, Martina, Zannad, Faiez, Packer, M

Journal:

European Journal of Heart Failure

Year:

2019

File:

PDF, 296 KB

2019

4

Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial

Anker, Stefan D., Butler, Javed, Filippatos, Gerasimos S., Jamal, Waheed, Salsali, Afshin, Schnee, Janet, Kimura, Karen, Zeller, Cordula, George, Jyothis, Brueckmann, Martina, Zannad, Faiez, Packer, M

Journal:

European Journal of Heart Failure

Year:

2019

Language:

english

File:

PDF, 296 KB

english, 2019

5

Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension

Tikkanen, Ilkka, Narko, Kirsi, Zeller, Cordula, Green, Alexandra, Salsali, Afshin, Broedl, Uli C., Woerle, Hans J.

Journal:

Year:

2015

Language:

english

File:

PDF, 1.28 MB

english, 2015

6

Effect of Gemfibrozil, Rifampicin, or Probenecid on the Pharmacokinetics of the SGLT2 Inhibitor Empagliflozin in Healthy Volunteers

Macha, Sreeraj, Koenen, Rüdiger, Sennewald, Regina, Schöne, Katja, Hummel, Noemi, Riedmaier, Stephan, Woerle, Hans J., Salsali, Afshin, Broedl, Uli C.

Journal:

Clinical Therapeutics

Year:

2014

Language:

english

File:

PDF, 331 KB

english, 2014

7

EMPAGLIFLOZIN IMPROVES BLOOD PRESSURE AS WELL AS GLYCEMIC CONTROL IN AFRICAN AMERICAN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION: A 24-WEEK RANDOMIZED CONTROLLED TRIAL

Ferdinand, Keith C., Lee, Jisoo, Meng, Leslie, George, Jyothis, Salsali, Afshin, Seman, Leo

Journal:

Journal of the American College of Cardiology

Year:

2018

Language:

english

File:

PDF, 417 KB

english, 2018

8

Pharmacokinetic and Pharmacodynamic Properties and Tolerability of Single- and multiple-dose Once-daily Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, in Chinese Patients With Type 2 Diabetes Mellitus

Zhao, Xia, Cui, Yimin, Zhao, Shuai, Lang, Benjamin, Broedl, Uli C., Salsali, Afshin, Pinnetti, Sabine, Macha, Sreeraj

Journal:

Clinical Therapeutics

Year:

2015

Language:

english

File:

PDF, 421 KB

english, 2015

9

Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, in Japanese Patients With Type 2 Diabetes Mellitus

Sarashina, Akiko, Ueki, Kohjiro, Sasaki, Tomohiro, Tanaka, Yuko, Koiwai, Kazuki, Sakamoto, Wataru, Woerle, Hans J., Salsali, Afshin, Broedl, Uli C., Macha, Sreeraj

Journal:

Clinical Therapeutics

Year:

2014

Language:

english

File:

PDF, 258 KB

english, 2014

10

Efficacy and safety of empagliflozin in patients with type 2 diabetes from Asian countries: pooled data from four phase III trials

Yoon, Kun-Ho, Nishimura, Rimei, Lee, Jisoo, Crowe, Susanne, Salsali, Afshin, Hach, Thomas, Woerle, Hans J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 1.22 MB

english, 2016

11

Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?

Salsali, Afshin, Pratley, Richard E

Journal:

Nature Clinical Practice Endocrinology and Metabolism

Year:

2007

Language:

english

File:

PDF, 89 KB

english, 2007

12

Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes

Rosenstock, Julio, Jelaska, Ante, Frappin, Guillaume, Salsali, Afshin, Kim, Gabriel, Woerle, Hans J., Broedl, Uli C.

Journal:

Year:

2014

Language:

english

File:

PDF, 1.43 MB

english, 2014

13

Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study

Nishimura, Rimei, Tanaka, Yuko, Koiwai, Kazuki, Inoue, Kohei, Hach, Thomas, Salsali, Afshin, Lund, Søren S, Broedl, Uli C

Journal:

Cardiovascular Diabetology

Year:

2015

Language:

english

File:

PDF, 1.16 MB

english, 2015

14

Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus

Kovacs, Christopher S., Seshiah, Veeraswamy, Merker, Ludwig, Christiansen, Anita Vedel, Roux, Flavien, Salsali, Afshin, Kim, Gabriel, Stella, Peter, Woerle, Hans-Juergen, Broedl, Uli C.

Journal:

Clinical Therapeutics

Year:

2015

Language:

english

File:

PDF, 689 KB

english, 2015

15

Empagliflozin Improves Blood Pressure in Patients with Type 2 Diabetes (T2DM) and Hypertension

Tikkanen, Ilkka, Narko, Kirsi, Zeller, Cordula, Green, Alexandra, Salsali, Afshin, Broedl, Uli C., Woerle, Hans J., Bajaj, Harpreet Singh

Journal:

Canadian Journal of Diabetes

Year:

2013

Language:

english

File:

PDF, 44 KB

english, 2013

16

Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial

Roden, Michael, Merker, Ludwig, Christiansen, Anita Vedel, Roux, Flavien, Salsali, Afshin, Kim, Gabriel, Stella, Peter, Woerle, Hans J., Broedl, Uli C.

Journal:

Cardiovascular Diabetology

Year:

2015

Language:

english

File:

PDF, 1.67 MB

english, 2015

17

Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

Packer, Milton, Butler, Javed, Filippatos, Gerasimos S., Jamal, Waheed, Salsali, Afshin, Schnee, Janet, Kimura, Karen, Zeller, Cordula, George, Jyothis, Brueckmann, Martina, Anker, Stefan D., Zannad,

Journal:

European Journal of Heart Failure

Year:

2019

Language:

english

File:

PDF, 873 KB

english, 2019

18

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME ® trial

Fitchett, David, Zinman, Bernard, Wanner, Christoph, Lachin, John M., Hantel, Stefan, Salsali, Afshin, Johansen, Odd Erik, Woerle, Hans J., Broedl, Uli C., Inzucchi, Silvio E.

Journal:

European Heart Journal

Year:

2016

Language:

english

File:

PDF, 465 KB

english, 2016

19

Pituitary tumor diagnosis and treatment

Paul L. Penar, David J. Nathan, Muriel H. Nathan, Afshin Salsali

Journal:

Current Neurology and Neuroscience Reports

Year:

2002

Language:

english

File:

PDF, 555 KB

english, 2002

20

Design of a 24-week trial of empagliflozin once daily in hypertensive Black/African American patients with type 2 diabetes mellitus

Ferdinand, Keith C., Seman, Leo, Salsali, Afshin

Journal:

Current Medical Research and Opinion

Year:

2017

Language:

english

File:

PDF, 895 KB

english, 2017

21

Efficacy and Safety of Empagliflozin (EMPA) in Younger, Overweight/Obese Patients with Type 2 Diabetes (T2DM) with HbA1c ≥8%

Merker, Ludwig, Lund, Soeren S., Hantel, Stefan, Salsali, Afshin, Kim, Gabriel, Broedl, Uli, Woerle, Hans J., Hach, Thomas

Journal:

Canadian Journal of Diabetes

Year:

2014

Language:

english

File:

PDF, 107 KB

english, 2014

22

Analysis of Fractures in Patients With Type 2 Diabetes Treated With Empagliflozin in Pooled Data From Placebo-Controlled Trials and a Head-to-Head Study Versus Glimepiride

Kohler, Sven, Kaspers, Stefan, Salsali, Afshin, Zeller, Cordula, Woerle, Hans J.

Journal:

Year:

2018

Language:

english

File:

PDF, 1.18 MB

english, 2018

23

Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetes

Zimdahl, Heike, Haupt, Axel, Brendel, Michael, Bour, Louis, Machicao, Fausto, Salsali, Afshin, Broedl, Uli C., Woerle, Hans-Juergen, Häring, Hans-Ulrich, Staiger, Harald

Journal:

Pharmacogenetics and Genomics

Year:

2017

Language:

english

File:

PDF, 155 KB

english, 2017

24

Antihyperglycemic and Blood Pressure Effects of Empagliflozin in African Americans with Type 2 Diabetes and Hypertension

Ferdinand, Keith C., Izzo, Joseph L., Lee, Jisoo, Meng, Leslie, George, Jyothis, Salsali, Afshin, Seman, Leo

Journal:

Year:

2019

File:

PDF, 2.33 MB

2019

25

Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure

Abraham, William T., Ponikowski, Piotr, Brueckmann, Martina, Zeller, Cordula, Macesic, Hemani, Peil, Barbara, Brun, Michèle, Ustyugova, Anastasia, Jamal, Waheed, Salsali, Afshin, Lindenfeld, JoAnn, An

Journal:

European Journal of Heart Failure

Year:

2019

Language:

english

File:

PDF, 178 KB

english, 2019

26

Kidney Function After Initiation And Discontinuation Of Empagliflozin (EMPA) In Heart Failure (HF) Patients (Pts) With And Without Type 2 Diabetes (T2D): Insights From The Emperial Trials

Anker, Stefan D., Ponikowski, Piotr, Wanner, Christoph, Pfarr, Egon, Hauske, Sibylle, Peil, Barbara, Salsali, Afshin, Ritter, Ivana, Nordaby, Matias, Koitka-Weber, Audrey, Brueckmann, Martina, Jamal,

Journal:

Journal of Cardiac Failure

Year:

2020

File:

PDF, 210 KB

2020

27

Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes

Kohler, Sven, Salsali, Afshin, Hantel, Stefan, Kaspers, Stefan, Woerle, Hans J., Kim, Gabriel, Broedl, Uli C.

Journal:

Clinical Therapeutics

Year:

2016

Language:

english

File:

PDF, 441 KB

english, 2016

28

Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes

Pratley, Richard E., Salsali, Afshin

Journal:

Current Medical Research and Opinion

Year:

2007

Language:

english

File:

PDF, 1.02 MB

english, 2007

29

Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes

Haering, Hans-Ulrich, Merker, Ludwig, Christiansen, Anita Vedel, Roux, Flavien, Salsali, Afshin, Kim, Gabriel, Meinicke, Thomas, Woerle, Hans J., Broedl, Uli C.

Journal:

Diabetes Research and Clinical Practice

Year:

2015

Language:

english

File:

PDF, 471 KB

english, 2015

30

A Review of Types 1 and 2 Diabetes Mellitus and Their Treatment with Insulin

Salsali, Afshin, Nathan, Muriel

Journal:

American Journal of Therapeutics

Year:

2006

Language:

english

File:

PDF, 161 KB

english, 2006

31

Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

Packer, Milton, Butler, Javed, Filippatos, Gerasimos S., Jamal, Waheed, Salsali, Afshin, Schnee, Janet, Kimura, Karen, Zeller, Cordula, George, Jyothis, Brueckmann, Martina, Anker, Stefan D., Zannad,

Journal:

European Journal of Heart Failure

Year:

2019

File:

PDF, 873 KB

2019

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски